+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bone Grafts & Substitutes Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011044
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bone Grafts & Substitutes Market grew from USD 3.56 billion in 2024 to USD 3.80 billion in 2025. It is expected to continue growing at a CAGR of 6.65%, reaching USD 5.24 billion by 2030.

The bone grafts and substitutes market has emerged as a critical pillar of orthopedic and dental care, driven by an ageing population, rising incidence of trauma and degenerative conditions, and rapid technological advancements. With healthcare systems under pressure to deliver cost-effective and high-quality outcomes, grafting materials that promote osseointegration and expedite recovery have gained strategic importance. Regenerative medicine innovations-from stem cell-based autografts to advanced synthetic ceramics and polymers-are reshaping clinical protocols and patient expectations alike. As surgical techniques evolve, minimally invasive procedures demand graft materials that balance handling characteristics with robust biological performance. Concurrently, regulatory landscapes are adapting to assess safety and efficacy for next-generation substitutes, fostering both opportunity and complexity. This executive summary offers a comprehensive overview of transformative trends, policy impacts, segmentation insights, regional dynamics, competitive positioning and actionable guidance to inform decision-making in this dynamic arena.

Transformative Shifts Reshaping the Bone Graft Landscape

Over the past decade, several transformative shifts have redefined the landscape of bone grafts and substitutes. First, biomaterials have evolved from basic demineralized matrices to multifunctional scaffolds that deliver bioactive molecules and recruit host cells. Advances in additive manufacturing and 3D printing now enable patient-specific graft designs, optimizing fit and reducing intraoperative time. Second, minimally invasive surgical approaches are mainstreaming graft substitutes whose handling properties support percutaneous delivery and predictable resorption profiles. Third, digital planning platforms integrate imaging, biomechanical modeling and surgical navigation, offering unprecedented precision in graft placement. Fourth, regulatory frameworks in key markets are streamlining approval pathways for regenerative products while tightening post-market surveillance to ensure long-term safety and performance. Fifth, strategic alliances and consolidation among device innovators, contract manufacturers and tissue banks are reshaping supply chains, improving scale but demanding rigorous quality governance. Finally, emerging market dynamics in Asia-Pacific and Latin America are highlighting the importance of cost-effective substitutes, driving tiered pricing strategies and local manufacturing partnerships. Together, these shifts underscore a market in flux, where technology adoption, regulatory alignment and value-based care will determine the winners of tomorrow.

Cumulative Impact of United States Tariffs, 2025

The implementation of new United States tariffs in 2025 has substantially impacted manufacturers and healthcare providers reliant on imported graft materials and raw inputs. Tariffs imposed on ceramic precursors such as calcium phosphate and sulfate, as well as specialized polymers like polyglycolic and polylactic acid, have increased production costs and exerted upward pressure on list prices. Allograft and xenograft suppliers have faced similar headwinds, as import duties on proprietary processing equipment and packaging materials have driven adjustments in cost structures. In response, some industry players have accelerated the localization of manufacturing, establishing bone graft processing facilities closer to end markets to mitigate duty exposure and enhance supply chain resilience. Healthcare systems, already managing budget constraints, are negotiating value-based contracts to cap reimbursement per procedure and align price with outcomes. Meanwhile, R&D teams are intensifying efforts to develop domestically sourced biomaterials, optimizing synthetic formulations that rely on non-tariffed minerals and exploring partnerships with academic institutions for novel polymer derivatives. Although short-term margin compression is evident, these strategic adaptations are poised to foster a more diversified, onshore supply base and a stronger focus on cost-effective innovation.

Key Segmentation Insights

An in-depth segmentation analysis reveals nuanced market trends and growth pockets. Based on Type, the market encompasses allograft options such as demineralized bone matrix and fresh/frozen grafts; autografts delivered through traditional surgical harvest or stem cell-enhanced grafts; synthetics divided into ceramic scaffolds including bioactive glass, calcium phosphate and calcium sulfate, as well as polymers like polyglycolic acid and polylactic acid; and xenografts derived from bovine and porcine sources. Application segmentation spans craniomaxillofacial surgeries, dental restorations, hip and knee joint reconstructions, spinal fusion procedures covering cervical, lumbar and thoracic levels, and trauma cases involving long bone and skull fractures. End users range from ambulatory surgical centers to private and public hospitals, research and academic institutions, and specialty outlets such as dental and orthopedic clinics. Material form preferences exhibit shifts toward blocks and wedges for load-bearing repairs, granules and particulates for irregular defects, preformed membranes and tapes for guided tissue regeneration, and injectable putty or paste for minimally invasive applications. Technique segmentation differentiates minimally invasive interventions-valued for reduced recovery time and infection risk-from traditional open grafting methods. This granular view underscores the importance of aligning product portfolios with specific clinical workflows, anatomical requirements and end-user expectations.

Key Regional Insights

Regional dynamics continue to drive strategic focus across the globe. In the Americas, robust reimbursement frameworks, high healthcare spending, and leading academic centers drive early adoption of advanced biomaterials and digital surgical solutions. Latin American markets, while price sensitive, are witnessing growth in trauma-related demand and partnerships for local graft processing. Across Europe, Middle East & Africa, regulatory harmonization within the EU facilitates pan-regional product launches, while Gulf Cooperation Council nations invest heavily in healthcare infrastructure, favoring high-performance graft substitutes. Conversely, Africa’s fragmented healthcare delivery presents access challenges but significant upside for cost-effective, off-the-shelf synthetics. The Asia-Pacific region is a hotbed of expansion, with aging societies in Japan and South Korea demanding innovative spinal fusion and joint reconstruction solutions, while China and India scale mass screening and trauma care networks; these markets emphasize tiered pricing models and domestic collaborations to balance affordability with cutting-edge performance. Overall, each region exhibits distinct adoption curves, reimbursement policies and competitive dynamics, requiring tailored market entry and commercialization strategies.

Key Company and Competitive Insights

Competitive intensity in the bone grafts and substitutes market is escalating as established medtech giants and agile startups vie for stake. AlloSource, Inc. and Musculoskeletal Transplant Foundation maintain leadership in allograft distribution, leveraging extensive tissue banking networks. Large diversified players such as Baxter International Inc, Johnson & Johnson Services, Inc., Medtronic PLC and Stryker Corporation are advancing proprietary synthetic platforms and 3D-printed scaffolds, often through strategic acquisitions of niche innovators like Graftys SA, SigmaGraft Inc. and OST Développement. Arthrex, Inc. and Nuvasive, Inc. integrate graft substitutes within broader implant and instrumentation portfolios, capitalizing on cross-selling opportunities. Specialist firms-including Bioventus, Geistlich Pharma AG, MedBone Biomaterials and Zimmer Biomet Holdings, Inc.-focus on differentiated formulations, from bioactive glass composites to polymer-ceramic hybrids. Contract manufacturers and engineering partners such as RTI Surgical, Inc. and TBF Tissue Engineering are expanding capacity to support both OEM clients and private-label programs. Meanwhile, emerging entities like Southern Implants and Anand Mediproducts Pvt Ltd are gaining traction in regional markets through cost-competitive offerings. These developments underscore the importance of robust R&D pipelines, manufacturing scalability and strategic alliances to sustain growth in a crowded landscape.

Actionable Recommendations for Industry Leaders

To navigate this complex environment, industry leaders should pursue five strategic imperatives. First, bolster R&D investment in next-generation biomaterials that combine structural integrity with bioactive cues, driving differentiation and premium positioning. Second, accelerate local manufacturing capabilities and dual sourcing models to mitigate tariff risks and enhance supply chain resilience. Third, strengthen value-based contracting with payers and health systems, leveraging real-world evidence to demonstrate superior clinical outcomes and cost efficiencies. Fourth, forge partnerships with digital surgery and imaging providers to deliver integrated solutions that streamline preoperative planning and intraoperative guidance. Fifth, tailor commercialization strategies to regional reimbursement landscapes, engaging local KOLs and regulatory experts to expedite market access. By aligning these initiatives, leaders can capitalize on emerging growth pockets, mitigate macroeconomic headwinds and solidify their roles as frontrunners in the bone grafts and substitutes domain.

Conclusion: Synthesizing Strategic Imperatives

In summary, the bone grafts and substitutes market stands at an inflection point shaped by material innovation, policy shifts and evolving clinical practices. Contemporary trends-ranging from 3D-printed patient-specific scaffolds to minimally invasive delivery systems-present both opportunities and execution challenges. Tariff-driven cost pressures underscore the imperative for onshore capabilities and supply diversification, while segmentation and regional insights highlight the need for tailored product and go-to-market strategies. Competitive dynamics favor organizations that combine deep scientific expertise, scalable manufacturing and strategic partnerships. As healthcare stakeholders increasingly demand evidence-backed therapies, companies that invest in outcome-driven research and foster value-based collaboration will achieve sustainable growth. This executive summary offers a roadmap to capitalize on current momentum and prepare for the next wave of advancements in bone graft technology.

Market Segmentation & Coverage

This research report categorizes the Bone Grafts & Substitutes Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Allograft Type
    • Demineralized Bone Matrix
    • Fresh/Frozen Allograft
  • Autograft Type
    • Bone Grafts Through Surgery
    • Stem Cell Based Grafts
  • Synthetics Type
    • Ceramic Based Grafts
      • Bioactive Glass
      • Calcium Phosphate
      • Calcium Sulfate
    • Polymers Based Grafts
      • Polyglycolic Acid
      • Polylactic Acid
  • Xenograft Type
    • Bovine Source
    • Porcine Source
  • Craniomaxillofacial Surgeries
  • Dental
  • Joint Reconstruction
    • Hip Joint
    • Knee Joint
  • Spinal Fusion
    • Cervical Fusion
    • Lumbar Fusion
    • Thoracic Fusion
  • Trauma Cases
    • Long Bone Fractures
    • Skull Related Fractures
  • Ambulatory Surgical Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Research & Academic Institutes
  • Specialty Clinics
    • Dental Clinics
    • Orthopedic Clinics
  • Blocks & Wedges
  • Granules & Particulates
  • Membranes & Tapes
  • Putty & Paste
  • Minimally Invasive Techniques
  • Traditional Grafting

This research report categorizes the Bone Grafts & Substitutes Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bone Grafts & Substitutes Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AlloSource, Inc.
  • Anand Mediproducts Pvt Ltd
  • Arthrex, Inc.
  • Baxter International Inc
  • Bioventus
  • Danaher Corporation
  • Encore Medical Corporation
  • Geistlich Pharma AG
  • Graftys SA
  • Institut Straumann AG
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • MedBone Biomaterials
  • Medtronic PLC
  • Musculoskeletal Transplant Foundation
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • OST Développement
  • RTI Surgical, Inc.
  • SigmaGraft Inc.
  • Smith & Nephew, PLC
  • Southern Implants
  • Stryker Corporation
  • TBF Tissue Engineering
  • Zimmer Biomet Holdings, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bone Grafts & Substitutes Market, by Type
8.1. Introduction
8.2. Allograft Type
8.2.1. Demineralized Bone Matrix
8.2.2. Fresh/Frozen Allograft
8.3. Autograft Type
8.3.1. Bone Grafts Through Surgery
8.3.2. Stem Cell Based Grafts
8.4. Synthetics Type
8.4.1. Ceramic Based Grafts
8.4.1.1. Bioactive Glass
8.4.1.2. Calcium Phosphate
8.4.1.3. Calcium Sulfate
8.4.2. Polymers Based Grafts
8.4.2.1. Polyglycolic Acid
8.4.2.2. Polylactic Acid
8.5. Xenograft Type
8.5.1. Bovine Source
8.5.2. Porcine Source
9. Bone Grafts & Substitutes Market, by Application
9.1. Introduction
9.2. Craniomaxillofacial Surgeries
9.3. Dental
9.4. Joint Reconstruction
9.4.1. Hip Joint
9.4.2. Knee Joint
9.5. Spinal Fusion
9.5.1. Cervical Fusion
9.5.2. Lumbar Fusion
9.5.3. Thoracic Fusion
9.6. Trauma Cases
9.6.1. Long Bone Fractures
9.6.2. Skull Related Fractures
10. Bone Grafts & Substitutes Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research & Academic Institutes
10.5. Specialty Clinics
10.5.1. Dental Clinics
10.5.2. Orthopedic Clinics
11. Bone Grafts & Substitutes Market, by Material Form
11.1. Introduction
11.2. Blocks & Wedges
11.3. Granules & Particulates
11.4. Membranes & Tapes
11.5. Putty & Paste
12. Bone Grafts & Substitutes Market, by Technique
12.1. Introduction
12.2. Minimally Invasive Techniques
12.3. Traditional Grafting
13. Americas Bone Grafts & Substitutes Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Bone Grafts & Substitutes Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Bone Grafts & Substitutes Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AlloSource, Inc.
16.3.2. Anand Mediproducts Pvt Ltd
16.3.3. Arthrex, Inc.
16.3.4. Baxter International Inc
16.3.5. Bioventus
16.3.6. Danaher Corporation
16.3.7. Encore Medical Corporation
16.3.8. Geistlich Pharma AG
16.3.9. Graftys SA
16.3.10. Institut Straumann AG
16.3.11. Integra LifeSciences Corporation
16.3.12. Johnson & Johnson Services, Inc.
16.3.13. MedBone Biomaterials
16.3.14. Medtronic PLC
16.3.15. Musculoskeletal Transplant Foundation
16.3.16. Nuvasive, Inc.
16.3.17. Orthofix Holdings, Inc.
16.3.18. OST Développement
16.3.19. RTI Surgical, Inc.
16.3.20. SigmaGraft Inc.
16.3.21. Smith & Nephew, PLC
16.3.22. Southern Implants
16.3.23. Stryker Corporation
16.3.24. TBF Tissue Engineering
16.3.25. Zimmer Biomet Holdings, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BONE GRAFTS & SUBSTITUTES MARKET MULTI-CURRENCY
FIGURE 2. BONE GRAFTS & SUBSTITUTES MARKET MULTI-LANGUAGE
FIGURE 3. BONE GRAFTS & SUBSTITUTES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BONE GRAFTS & SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BONE GRAFTS & SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BONE GRAFTS & SUBSTITUTES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY FRESH/FROZEN ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BONE GRAFTS THROUGH SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY STEM CELL BASED GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BOVINE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PORCINE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HIP JOINT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY KNEE JOINT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERVICAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY LUMBAR FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY THORACIC FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY LONG BONE FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SKULL RELATED FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY BLOCKS & WEDGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY GRANULES & PARTICULATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MEMBRANES & TAPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY PUTTY & PASTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MINIMALLY INVASIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRADITIONAL GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 114. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 116. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 117. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 119. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 120. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 121. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 123. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 124. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 125. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 127. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 129. CANADA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 196. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 198. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 199. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 200. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 201. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 202. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 203. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 205. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 206. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 207. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 211. CHINA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 212. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 214. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 215. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 217. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 218. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 219. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 221. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 222. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 223. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 225. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 226. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 227. INDIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 244. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 246. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 247. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 248. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 249. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 250. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 251. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 253. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 254. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 294. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 295. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 296. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 297. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 298. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY ALLOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY AUTOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SYNTHETICS TYPE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY CERAMIC BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY POLYMERS BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY XENOGRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY HOSPITALS,

Companies Mentioned

  • AlloSource, Inc.
  • Anand Mediproducts Pvt Ltd
  • Arthrex, Inc.
  • Baxter International Inc
  • Bioventus
  • Danaher Corporation
  • Encore Medical Corporation
  • Geistlich Pharma AG
  • Graftys SA
  • Institut Straumann AG
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • MedBone Biomaterials
  • Medtronic PLC
  • Musculoskeletal Transplant Foundation
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • OST Développement
  • RTI Surgical, Inc.
  • SigmaGraft Inc.
  • Smith & Nephew, PLC
  • Southern Implants
  • Stryker Corporation
  • TBF Tissue Engineering
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...